weight loss plateau management glp-1 medications Specialist in Langhorne and Philadelphia, PA TrimRX | How to Adjust

The primary mechanisms of action include: Enhanced insulin secretion : GLP-1 receptor agonists stimulate glucose-dependent insulin release from pancreatic beta cells, improving glycaemic control without causing hypoglycaemia when glucose levels are normal Suppressed glucagon secretion : These agents inhibit inappropriate glucagon release from pancreatic alpha cells, reducing hepatic glucose production Delayed gastric emptying : By slowing the rate at which food leaves the stomach, GLP-1 medications prolong satiety and reduce postprandial glucose excursions Central appetite regulation : GLP-1 receptors in the hypothalamus and brainstem mediate reduced appetite and food intake, leading to decreased caloric consumption Regarding visceral fat specifically, some imaging substudies suggest GLP-1 receptor agonists may reduce visceral adipose tissue alongside subcutaneous fat

Additionally, GLP-1RAs slow gastric emptying, enhancing the feeling of fullness and reducing overall caloric intake, making them effective for weight management

Prescribing Information: Saxenda (liraglutide) injection, for subcutaneous use

GLP-1 receptor agonists (often mistakenly called GLP-1 inhibitors) mimic your bodys natural GLP-1